Oracle, Shares

Oracle Shares Face Critical Test as Technical and Fundamental Views Diverge

08.01.2026 - 12:00:04

Oracle US68389X1054

Oracle's stock encountered significant selling pressure on Thursday, with a key technical indicator flashing a bearish signal just as Wall Street analysts presented starkly opposing views on the company's trajectory. The emergence of a "death cross" pattern—where the 50-day moving average falls below the 200-day moving average—has amplified concerns for chart-focused traders. This development arrives as Oracle's share price trades approximately 40% below its 52-week high, intensifying scrutiny on its near-term direction.

The investment community is deeply divided on Oracle's prospects, a split crystallized by two dramatically different price targets. Analysts at RBC Capital have taken a decidedly cautious stance, slashing their target to $195 from $250. Their warning centers on what they see as inflated market expectations for growth in artificial intelligence, suggesting Oracle may struggle to meet ambitious near-term forecasts. From RBC's perspective, this leaves limited room for upward movement from current levels.

In stark contrast, Jefferies reiterated its bullish "buy" rating this week, maintaining a $400 price objective. Their analysts argue the recent sell-off is overdone, pointing to Oracle's strong positioning within the AI infrastructure market. They highlight the company's substantial backlog of data center contracts, which they believe provides a solid foundation for future growth. This view was echoed in mid-December by Evercore ISI, which also noted a backlog covering over seven gigawatts of capacity.

Should investors sell immediately? Or is it worth buying Oracle?

The chasm between the $195 and $400 targets underscores the extreme uncertainty surrounding Oracle's ability to monetize the current AI investment boom.

Strong Earnings Mask Underlying Investment Strain

Oracle's fundamental performance has shown strength, with the company reporting second-quarter earnings per share of $2.26 in December, significantly surpassing the $1.64 consensus estimate. However, the capital-intensive nature of its infrastructure expansion presents a challenge. The company's debt-to-equity ratio stands at 3.28, a level that conservative investors may view as a risk factor. The central question for the market is not whether Oracle can generate revenue, but rather the timing of when its substantial contract backlog will convert into tangible earnings.

Key Technical Levels to Watch

With the death cross confirmed, technical analysts are focusing on several crucial price levels. Immediate support is seen around the $190 mark. A sustained break below this level could open the path toward $175. For the bearish momentum to be countered, Oracle shares would need to reclaim and hold above the psychologically important $200 threshold. Investor focus now shifts to the next quarterly results, due in mid-March, with volatility expected to remain elevated until then.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from January 8 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 8.

Oracle: Buy or sell? Read more here...

@ boerse-global.de | US68389X1054 ORACLE